Market Forecast By Technology (Quantitative PCR, Digital PCR), By Application (Clinical ApplicationsResearch Applications, Pathogen Testing, Oncology Testing, Blood Screening, Others (Food Safety and Environmental Monitoring)), By End User (Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharmaceutical & Biotechnology Companies, Clinical Research Organizations, Forensic Laboratories) and Competitive lanscape
Product Code: ETC10152998 | Publication Date: Jan 2025 | Updated Date: Jan 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 62 | No. of Figures: 11 | No. of Tables: 3 | |
Portugal Real-Time PCR And Digital PCR Market Report thoroughly covers the market by technology, application and end user. Portugal Real-Time PCR And Digital PCR Market Outlook report provides an unbiased and detailed analysis of the ongoing Portugal Real-Time PCR And Digital PCR Market trends, opportunities/high growth areas, and market drivers. This would help stakeholders devise and align their market strategies according to the current and future market dynamics.
The Portugal Real-Time PCR And Digital PCR Market has experienced significant expansion in recent years, driven by growing investments in healthcare, biotechnology, and pharmaceuticals, Portugal has made remarkable strides in enhancing its diagnostic and public health capabilities. Between 2018 and 2022, the country’s healthcare sector witnessed significant funding increases, resulting in tangible improvements, such as a rise in the number of hospitals from 230 to 243. This growth reflects Portugal’s commitment to strengthening its healthcare infrastructure and ensuring better access to advanced medical technologies for its population.
According to 6wresearch, Portugal Real-Time PCR And Digital PCR Market size is projected to grow at a CAGR of 4.1% during 2024-2030F. driven by advancements in healthcare infrastructure, biotechnology, and diagnostic research. Investments in these sectors have fueled the adoption of cutting-edge PCR technologies, catering to both clinical diagnostics and research applications. Such as, Portugal's healthcare sector has seen consistent funding growth, with initiatives aimed at modernizing diagnostic capabilities and expanding access to advanced medical tools. Additionally, collaborations between public institutions and private companies have accelerated research efforts, particularly in infectious disease diagnostics and genomic studies, further driving market demand.
Quantitative PCR command a significant portion of the revenue as compared to Digital PCR due to their crucial role in diagnostics and research across healthcare, biotechnology. Additionally, in terms of end-users, hospitals and diagnostic centers have claimed the largest portion, his dominance is primarily attributed to the extensive utilization of Quantitative PCR in these facilities for clinical diagnostics, including infectious diseases, oncology, and genetic testing. Its reliability, speed, and accuracy make it a cornerstone in routine diagnostic workflows, enabling hospitals and diagnostic centers to deliver precise and timely results for patient care.
During the forecast period, Digital PCR are projected to lead the Portugal Real-Time PCR And Digital PCR Market owing to dPCR offers unparalleled sensitivity and quantification capabilities compared to traditional Quantitative PCR (qPCR). This makes it ideal for detecting rare mutations, minimal residual disease in cancer patients, and low-level viral loads.
During the forecast period, oncology testing are projected to lead the Portugal Real-Time PCR And Digital PCR Market owing to The increasing prevalence of cancer in Portugal, creating an urgent need for advanced diagnostic tools like real-time and digital PCR for early detection, monitoring, and personalized treatment planning.
By End User, Pharma and biotech companies are expected to witness the highest growth in in future driven by increasing investments in personalized medicine, biologics, and infectious disease diagnostics. For instance, companies like Bial and startups such as LiMM Therapeutics are leveraging PCR technologies for drug development and genomics research, while international collaborations further boost R&D initiatives.
The report provides a detailed analysis of the following market segments:
1. Executive Summary |
2. Introduction |
2.1 Report Description |
2.2 Key Highlights of the Report |
2.3 Market Scope and Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3. Portugal Real-Time PCR And Digital PCR Market Overview |
3.1 Portugal Real-Time PCR And Digital PCR Market Revenues (2020-2030F) |
3.2 Portugal Real-Time PCR And Digital PCR Market Industry Life Cycle |
3.3 Portugal Real-Time PCR And Digital PCR Market Porter Five Forces |
4. Portugal Real-Time PCR And Digital PCR Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraint |
5. Portugal Real-Time PCR And Digital PCR Market Trends & Evolution |
6. Portugal Real-Time PCR And Digital PCR Market Overview, By Technology |
6.1 Portugal Real-Time PCR And Digital PCR Market Revenue Share and Revenues, By Technology (2020-2030F) |
6.1.1 Portugal Real-Time PCR And Digital PCR Market Revenues, By Quantitative PCR (2020-2030F) |
6.1.2 Portugal Real-Time PCR And Digital PCR Market Revenues, By Digital PCR (2020-2030F) |
7. Portugal Real-Time PCR And Digital PCR Market Overview, By Application |
7.1 Portugal Real-Time PCR And Digital PCR Market Revenue Share and Revenues, Application (2020 & 2030F) |
7.1.1 Portugal Real-Time PCR And Digital PCR Market Revenues, By Clinical Applications (2020-2030F) |
7.1.2 Portugal Real-Time PCR And Digital PCR Market Revenues, By Research Application (2020-2030F) |
7.1.3 Portugal Real-Time PCR And Digital PCR Market Revenues, By Pathogen Testing (2020-2030F) |
7.1.4 Portugal Real-Time PCR And Digital PCR Market Revenues, By Oncology Testing (2020-2030F) |
7.1.5 Portugal Real-Time PCR And Digital PCR Market Revenues, By Blood Screening (2020-2030F) |
7.1.6 Portugal Real-Time PCR And Digital PCR Market Revenues, By Others (2020-2030F) |
8. Portugal Real-Time PCR And Digital PCR Market Overview, By End-User |
8.1 Portugal Real-Time PCR And Digital PCR Market Revenue Share and Revenues, End-User (2020 & 2030F) |
8.1.1 Portugal Real-Time PCR And Digital PCR Market Revenues, By Hospitals & Diagnostic Centers (2020-2030F) |
8.1.2 Portugal Real-Time PCR And Digital PCR Market Revenues, By Research Laboratories & Academic Institutes (2020-2030F) |
8.1.3 Portugal Real-Time PCR And Digital PCR Market Revenues, By Pharmaceutical & Biotechnology Companies (2020-2030F) |
8.1.4 Portugal Real-Time PCR And Digital PCR Market Revenues, By Clinical Research Organizations (2020-2030F) |
8.1.5 Portugal Real-Time PCR And Digital PCR Market Revenues, By Forensic Laboratories (2020-2030F) |
9. Portugal Real-Time PCR And Digital PCR Market Key Performance Indicators |
10. Portugal Real-Time PCR And Digital PCR Market Opportunity Assessment |
10.1 Portugal Real-Time PCR And Digital PCR Market Opportunity Assessment, By Technology (2030F) |
10.2 Portugal Real-Time PCR And Digital PCR Market Opportunity Assessment, By Application (2030F) |
10.3 Portugal Real-Time PCR And Digital PCR Market Opportunity Assessment, By End User (2030F) |
11. Portugal Real-Time PCR And Digital PCR Market Competitive Benchmarking |
11.1 Portugal Real-Time PCR And Digital PCR Market Revenue Ranking (2023), By Top 3 Companies |
11.2 Portugal Real-Time PCR And Digital PCR Market Competitive Benchmarking, By Operating Parameters |
12. Company Profiles |
12.1 Fisher Scientific |
12.2 QIAGEN |
12.3 NZYtech |
12.4 BIOPORTUGAL |
12.5 Biomerieux |
12.6 Altona Diagnostics |
12.7 Vitro Master Diagnóstica |
12.6 Roche |
12.7 Bio-Rad laboratories |
13. Key Strategic Recommendations |
14. Disclaimer |
List of Figures |
1. Portugal Real-Time PCR And Digital PCR Market Revenues, 2020-2030F ($ Miilion) |
2. Portugal Number of Hospitals, 2018 – 2022 |
3. Portugal Real-Time PCR And Digital PCR Market Revenue Share, By Technology, 2023 and 2030F |
4. Portugal Real-Time PCR And Digital PCR Market Revenue Share, By Application, 2023 and 2030F |
5. Portugal Real-Time PCR And Digital PCR Market Revenue Share, By End User, 2023 and 2030F |
6. Portugal Ageing-Related Spending is Projected to Increase Substantially, 2019-2070F (% of GDP) |
7.Portuguese Health Expenditure ($ Billion), 2020-2023 |
8. Portugal Real-Time PCR And Digital PCR Market Opportunity Assessment, By Technology, 2030F |
9. Portugal Real-Time PCR And Digital PCR Market Opportunity Assessment, By Application, 2030F |
10. Portugal Real-Time PCR And Digital PCR Market Opportunity Assessment, By End User, 2030F |
11. Portugal Real-time PCR, Digital PCR and End Point PCR Revenue Ranking, By Companies, 2023 |
List of Tables |
1. Portugal Real-Time PCR And Digital PCR Market Revenues, By Technology, 2020-2030F ($ Million) |
2. Portugal Real-Time PCR And Digital PCR Market Revenues, By Application, 2020-2030F ($ Million) |
3. Portugal Real-Time PCR And Digital PCR Market Revenues, By End User, 2020-2030F ($ Million) |